Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS☆

[1]  C. DeCarli,et al.  Predictors of brain morphology for the men of the NHLBI twin study. , 1999, Stroke.

[2]  Y. Yamamoto,et al.  Relationship between brain atrophy estimated by a longitudinal computed tomography study and blood pressure control in patients with essential hypertension. , 1999, Japanese circulation journal.

[3]  L. Allegri,et al.  Hypertension as an Etiopathological Factor in the Development of Cerebral Atrophy in Hemodialyzed Patients , 1999, Nephron.

[4]  C. DeCarli,et al.  Association of midlife blood pressure to late-life cognitive decline and brain morphology , 1998, Neurology.

[5]  K. Davis,et al.  The relationship between apolipoprotein E, dementia, and vascular illness. , 1998, Atherosclerosis.

[6]  M. Mullan,et al.  Characteristics of thein VitroVasoactivity of β-Amyloid Peptides , 1998, Experimental Neurology.

[7]  C. Kessler,et al.  Apolipoprotein E4 Promotes Incipient Alzheimer Pathology in the Elderly , 1998, Alzheimer disease and associated disorders.

[8]  W. Markesbery,et al.  N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.

[9]  Yasuo Terayama,et al.  Normal human aging: factors contributing to cerebral atrophy , 1997, Journal of the Neurological Sciences.

[10]  D. Davis,et al.  Microscope field size and the neuropathologic criteria for Alzheimer's disease , 1997, Neurology.

[11]  D. Sparks.  Coronary Artery Disease, Hypertension, ApoE, and Cholesterol: A Link to Alzheimer's Disease? , 1997, Annals of the New York Academy of Sciences.

[12]  J. Bogousslavsky,et al.  Presymptomatic hypertension is a major feature in the diagnosis of progressive supranuclear palsy. , 1997, Archives of neurology.

[13]  G. Alexander,et al.  Interactive effects of age and hypertension on volumes of brain structures. , 1997, Stroke.

[14]  S. M. Sumi,et al.  Clinical-neuropathologic findings in multi-infarct dementia , 1997, Neurology.

[15]  J. Lindsay,et al.  The Canadian Study of Health and Aging: risk factors for vascular dementia. , 1997, Stroke.

[16]  D J Foley,et al.  Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. , 1996, JAMA.

[17]  D. Sparks,et al.  Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients , 1996, Journal of the Neurological Sciences.

[18]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[19]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[20]  C. Morris,et al.  Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians , 1995, Neuroscience Letters.

[21]  D. Sparks,et al.  Increased incidence of neurofibrillary tangles (NFT) in non-demented individuals with hypertension , 1995, Journal of the Neurological Sciences.

[22]  T. Hashimoto,et al.  [A longitudinal study of brain atrophy and its relation with background factors and common carotid hemodynamics]. , 1994, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[23]  英忠 佐々木,et al.  アルツハイマー型老年痴呆 (SDAT) と「ビンスワンガー型白質病変」 , 1994 .

[24]  E P Steinberg,et al.  Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. , 1994, Stroke.

[25]  O. Faergeman,et al.  Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[26]  G. Baumbach.  Changes in the Cerebral Circulation in Chronic Hypertension , 1994 .

[27]  The Human Brain Circulation , 1994, Vascular Biomedicine.

[28]  R. D'Agostino,et al.  Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.

[29]  V. Hachinski,et al.  Rethinking Vascular Dementia (Part 1 of 2) , 1993 .

[30]  Y. Stern,et al.  Confusion and memory loss from capsular genu infarction , 1992, Neurology.

[31]  J. Haxby,et al.  Brain atrophy in hypertension. A volumetric magnetic resonance imaging study. , 1992, Hypertension.

[32]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[33]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .

[34]  Norman E. Breslow,et al.  Tests of Hypotheses in Overdispersed Poisson Regression and other Quasi-Likelihood Models , 1990 .

[35]  K. Arima,et al.  Severe cerebral atrophy in progressive supranuclear palsy: a case report. , 1989, Clinical neuropathology.

[36]  A. Paetau,et al.  Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[37]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.